Summary
Anti-idiotypic antibodies have proven to have unique applications as probes in both functional and biochemical studies of cell surface receptors. Anti-idiotypic receptor antibodies have been prepared to antibodies which bind to purified ligand, as in the case of insulin, retinol-binding protein, the mammalian reovirus receptor, and the neutrophil chemotatic receptor, and to natural ligand analogs, such as the beta-adrenergic antagonist alprenolol. These systems have documented the usefulness of anti-idiotypic antibodies in the quantitation and modulation of specific membrane receptors on a variety of cell types. Anti-idotypic antibodies have also been utilized for the isolation of specific membrane receptors, e.g., reovirus and B-1 H globulin receptors. Some anti-idiotypic receptor antibodies, e.g., insulin and reovirus systems, have been shown to mimic the physiological properties of ligand upon binding to cellular receptors. These antibodies enable a new dimension of both receptor based cellular studies and therapeutic regimens. This review focuses on the past use of anti-idiotypic antibodies as probes of cell surface receptors, and on the methodologies required for the successful application of anti-idiotypic antibodies for use in further membrane receptor studies, and of the genes which encode and regulate these receptors. We also discuss the use of anti-idiotypic antibodies in the understanding of and therapeutic approach to receptor related diseases.
Similar content being viewed by others
References
Jerne NK: Towards a network theory of the immune system. Ann Immunol 125c: 373–388, 1974.
Sirisinha S, Eisen H H: Autoimmune-like antibodies to the ligand-binding sites of myeloma proteins. Proc Natl Acad Sci USA 68: 3130–3135, 1971.
Cosenza H: Detection of anti-idiotype reactive cells in the response to phosphorylcholine. Eur J Immunol 6: 114–116, 1976.
Geha RS: Presence of auto-anti-idiotypic antibody during the normal human immune response to tetanus toxoid antigen. J Immunol 129: 139–144, 1982.
Hart DA, Wang A-L, Pawlak LL, Nisonoff A: Suppression of idiotypic specificities in adult mice by administration of anti-idiotypic antibody. J Exp Med 135: 1293–1300, 1972.
Owen FL, Ju S-T, Nisonoff A: Presence on idiotype-specific suppressor T cells of receptors that interact with molecules bearing the idiotype. J Exp Med 145: 1559–1566, 1977.
Dietz MH, Sy M-S, Benacerraf B, Nisonoff A, Greene MI, Germain RH: Antigen- and receptor-driven regulatory mechanisms. VII. H-2 restricted anti-idiotypic suppressor factor from efferent suppressor T cells. J Exp Med 153: 450–460, 1981.
Eichman K: Idiotypic suppression. II. Amplification of a suppressor T cell with anti-idiotypic activity. Eur J Immunol 5: 511–517, 1975.
Sege K, Peterson PA: Use of anti-idiotypic antibodies as cell-surface receptor probes. Proc Natl Acad Sci USA 75: 2443–2447, 1978.
Schreiber AB, Couraud PO, Andre C, Vray B, Strosberg DA: Anti-alprenolol anti-idiotypic antibodies bind to Badrenergic receptors and modulate catecholamine-sensitive adenylate cyclase. Proc Natl Acad Sci USA 77: 7385–7389, 1980.
Flier J, Kahn CR, Jarett DB, Roth J: Characterization of antibody to the insulin receptor. A case of insulin-resistant diabetes in man. J Clin Invest 58: 1442–1449, 1976.
Flier J, Kahn CR, Roth J, Bar R: Autoantibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance. Science 190: 63–65, 1975.
Hall R, Smith BR, Mukhtar ED: Thyroid stimulators in health and disease. Clin Endocrinol 4: 213–230, 1975.
Dwyer DS, Bradley RJ, Urquhart CK, Kearney JF: Naturally occurring anti-idiotypic antibodies in myasthenia gravis patients. Nature (London) 301: 611–614, 1983.
Wasserman NH, Penn AS, Freimuth PI, Treptow N, Wentzel S, Cleveland WL, Erlanger BF: Anti-idiotypic route to anti-acetylcholine receptor antibodies and experimental myasthenia gravis. Proc Natl Acad Sci USA 79: 4810–4814, 1982.
Goding JW: Biological effects of antibody to lymphocyte surface receptors. Springer Seminar Immunopathol 5: 463–475, 1982.
Venter JC: Monoclonal antibodies and autoantibodies in the isolation and characterization of neurotransmitter receptors: the future of receptor research. J Mol Cell Cardiol 14:687–693, 1982.
Strauss WL, Ghai G, Fraser CM, Venter JC: Detergent solubilization of mammalian cardiac and hepatic B-adrenergic receptors. Arch Biochem Biophys 196: 566–573, 1979.
Kull FC Jr, Jacobs S, Su Y-F, Cuatrecasas P: A monoclonal antibody to human insulin receptor. Biochem Biophys Res Commun 106: 1019–1026, 1982.
Kasuga M, Van Obberghan E, Yamada KM, Harrison LC: Autoantibodies against the insulin receptor recognize the insulin binding subunits of an oligomeric receptor. Diabetes 30: 354–357, 1981.
Kasuga M, Karlsson FA, Kahn CR: Insulin stimulates the phosphorylation of the 95000 dalton subunit of its own receptor. Science 215: 185–187, 1982.
Kasuga M, Fujito-Yamaguchi Y, Blithe DL, Kahn CR: Tyrosine specific protein kinase activity is associated with the purified insulin receptor. Proc Natl Acad Sci USA 80: 2137–2141, 1983.
Rosen OM, Herrera R, Lowe YO, Petruzzelli LM, Cobb MH: Phosphorylation activates the insulin receptor tyrosine protein kinase. Proc Natl Acad Sci USA 80: 3237–3240, 1983.
Roth RA, Cassell DJ: Insulin receptor: evidence that it is a protein kinase. Science 219: 299–310, 1983.
Taylor RB, Duffus WPH, Raff MC, dePetris S: Redistribution and pinocytosis of lymphocyte surface immunoglobulin molecules induced by anti-immunoglobulin antibody. Nature (New Biol) 233: 225–229, 1971.
Schreiner GF, Unanue ER: Membrane and cytoplasmic changes in B lymphocytes induced by ligand-surface immunoglobulin interaction. Adv Immunol 24:37–165, 1976.
Edelman GM: Surface modulation in cell recognition and cell growth. Science 192: 218–226, 1976.
Bourguignon LYW, Singer SJ: Transmembrane interactions and the capping of surface receptors by their specific ligands. Proc Natl Acad Sci USA 74: 5031–5035 1977.
Sege K, Peterson PA: Anti-idiotypic antibodies against anti-vitamin A transport protein reacts with prealbumin. Nature (London) 271: 167–168, 1978.
Shechter Y, Maron R, Elias D, Cohen IR: Autoantibodies to insulin receptor spontaneously develop as anti-idiotypes in mice immunized with insulin. Science 216: 542–545, 1982.
Couraud PO, Lu BZ, Schmutz A, Durieu-Trautmann O, Klutchko-Delavier C, Hoebeke J, Strosberg DA: Immunological studies of B-adrenergic receptors. J Cell Biochem (in press), 1983.
Homcy CJ, Rockson SG, Haber E: An anti-idiotypic antibody that recognizes the B-adrenergic receptor. J Clin Invest 69: 1147–1154, 1982.
Fraser CM, Venter JC: Monoclonal antibodies to B-adrenergoic receptors: use in purification and molecular characterization of B-receptors. Proc Natl Acad Sci USA 77: 7034–7038, 1980.
Fraser CM, Greguski R, Eddy B, Venter JC: Autoantibodies and monoclonal antibodies in the purification and molecular characterization of neurotransmitter receptors. J Cell Biochem (in press), 1983.
Venter JC, Fraser CM: Beta-adregnergic receptor isolation and characterization with immobilized drugs and monoclonal antibodies. Fed Proc 42: 123–128, 1983.
Marasco WA, Becker EL: Anti-idiotype as antibody against the formyl peptide chemotaxis receptor of the neutrophil. J Immunol 128: 963–968, 1982.
Lambris JD, Ross GD: Characterization of the lymphocyte membrane receptor for factor H (B1 H-globulin) with an antibody to anti-factor H idiotype. J Exp Med 155: 1400–1411, 1982.
Fields BN, Greene MI: Genetic and molecular mechanisms of viral pathogenesis: implications for prevention and treatment. Nature (London) 300: 19–23, 1982.
Burstin SJ, Spriggs DR, Fields BN: Evidence for functional domains on the reovirus type 3 hemagglutinin. Virology 117:146–155, 1982.
Greene MI, Weiner HL: Delayed hypersensitivity in mice infected with reovirus. III. Induction of tolerance and suppressor T cells to viral specific gene products. J Immunol 125:283–287, 1980.
Finberg R, Weiner HL, Fields BN, Benacerraf B, Burakoff SJ: Generation of cytolytic T lymphocytes after reovirus infection: role of S1 gene. Proc Natl Acad Sci USA 76: 442–446, 1979.
Nepom JT, Weiner HL, Dichter MA, Tardieu M, Spriggs DR, Gramm CF, Powers ML, Fields BN, Greene MI: Identification of a hemagglutinin-specific idiotype associated with reovirus recognition shared by lymphoid and neural cells. J Exp Med 155: 155–167, 1982.
Nepom JT, Tardieu M, Epstein RL, Noseworthy JH, Weiner HL, Gentsch J, Fields BN, Greene MI: Virus-binding receptors: similarities to immune receptors as determined by anti-idiotypic antibodies. Surv Immunol Res 1: 255–261, 1982.
Fontana A, Weiner HL: Interacting reovirus with cell surface receptors. II. Generation of suppressor T cells by the hemagglutinin of reovirus type 3. J Immunol 125: 2660–2664, 1980.
Noseworthy JH, Fields BN, Dichter MA, Sobotoka C, Pizer E, Perry LL, Nepom JT, Greene MI: Cell receptors for the mammalian reovirus. I. Syngeneic monoclonal antiidiotypic antibody identifies a cell surface receptor for reovirus. J Immunol 131: 2533–2538, 1983.
Kauffman RS, Noseworthy JH, Nepom JT, Finberg R, Fields BN, Greene MI: Cell receptors for the mammalian reovirus. II. Monoclonal anti-idiotypic antibody blocks viral binding to cells. J Immunol 131: 2539–2541, 1983.
Ertl HC, Greene MI, Noseworthy JH, Fields BN, Nepom JT, Spriggs DR, Finberg RW: Identification of idiotype receptors on reovirus-specific cytolytic T cells. Proc Natl Acad Sci USA 79: 7479–7483, 1983.
Sharpe AH, Ertl HCJ, Finberg RW, Fields BN, Greene, MI: Cell receptors for the mammalian reovirus. IV. Reovirus specific cytolytic T cell lines which have idiotypic receptors recognize anti-idiotypic B cell hybridomas. J Exp Med in press.
Jensenius JC, Williams AF: The T lymphocyte to antigen receptor — paradigm lost. Nature (London) 300: 583–388, 1982.
Kronenberg M, Kraig E. Hood L: Finding the T-cell antigen receptor: past attempts and future promise. Cell 34: 327–319, 1983.
Binz H, Wigzell H: Shared idiotypic determinants on B and T lymphocytes reactive against the same antigenic determinants. I. Demonstration of similar or identical idiotypes on IgG molecules and T cell receptors with specificity for the same alloantigens. J Exp Med 142: 197–211, 197–211, 1975.
Eichmann K, Rajewsky K: Induction of T and B cell immunity by anti-idiotypic antibody. Eur J Immunol 5: 661–666, 1975.
Black SJ, Hammerling GJ, Berek C, Rajewsky K, Eichmann K: Idiotypic analysis of lymphocytes in vitro. I. Specificity and heterogeneity of B and T lymphocytes reactive with anti-idiotypic antibody. J Exp Med 143: 846–860, 1976.
Krawinkel U, Cramer M, Imanishi-Kari T, Jack RS, Rajewsky K, Makela O: Isolated hapten-binding receptors of sensitized lymphocytes. I. Receptors from nylon-wool enriched mouse T lymphocytes lack serological markers of immunoglobulin constant domains but express heavy chain variable portions. Eur J Immunol 8: 566–573, 1977.
Binz H, Wigzell H: Shared idiotypic determinants on B and T lymphocytes reactive against the same antigenic determinants. IV. Isolation of two groups of naturally occurring. idiotypic molecules with specific antigen-binding activity in the serum and urine of normal rats. Scand J Immunol 4: 591–600, 1975.
Binz H, Wigzell H: Shared idiotypic determinants on B and T lymphocytes reactive against the same antigenic determinants. V. Biochemical and serological characteristics of naturally occurring antigen-binding T lymphocyte-derived molecules. Scand J Immunol 5: 559–571, 1976.
Hirai Y, Nisonoff A: Selective suppression of the major idiotypic component of an antihapten response by soluble T cell-derived factors with idiotypic or anti-idiotypic receptors. J Exp Med 151: 1213–1231, 1980.
Taniguchi M, Takei I, Tada T: Functional and molecular organisation of an antigen-specific suppressor factor from a T-cell hybridoma. Nature (London) 283: 227–228, 1981.
Tokuhisa T, Taniguchi M: Constant region determinants in the antigen-binding chain of the suppressor T-cell factor. Nature (London) 298: 174–176, 1982.
Garvey JS, Cremer NE, Sussdorf DH: Methods in Immunology. W.A. Benjamin, Inc, Reading, Massachusetts, 1977, pp 133–188.
Kristiansen T: Matrix-bound antibodies. In: Hoffman-Ostenhof O, (ed). Affinity Chromatography. Pergamon Press, Oxford, 1978, pp 191–206.
Zoller M, Matzku S: Antigen and antibody purification by immunoadsorption: elimination of non-biospecifically bound proteins. J Immunol Methods 11: 287–295, 1976.
Siekevitz M, Gefter ML, Brodeur P, Riblet R, MarshakRothstein A: The genetic basis of antibody production: the dominant anti-arsonate idiotype response of the strain A mouse. Eur J Immunol 12: 1023–1032, 1982.
Kohler G, Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature (London) 256: 495–497, 1975.
Hurrell JGR: Monoclonal Hybridoma Antibodies: Techniques and Applications. CRC Press, Inc, Boca Raton, Florida, 1982.
Simmons JG, Hutt-Fletcher M, Fowler E, Feighny RJ: Studies of the Epstein-Barr virus receptor found on Raji cells. I. Extraction of receptor and preparation of anti-receptor antibody. J Immunol 130: 1303–1308, 1983.
Leonard WJ, Depper JM, Robb RJ, Waldmann TA, Greene WC: Characterization of the human receptor for T-cell growth factor. Proc Natl Acad Sci USA 80: 6957–6961, 1983.
Southern EM: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98: 503–517, 1975.
Renant JR, Reiser J, Stark GR: Transfer of proteins from gels to diazobenzyloxymethyl-paper and detection with antisera: a method for studying antibody specificity and antigen structure. Proc Natl Acad Sci USA 76: 3116–3120, 1979.
Young-Kaplan BR, Ashman RF: Order of events leading to surface immunoglobulin capping: analysis of a transmembrane signal. J Immunol 123: 1177–1181, 1981.
Williams JM, Shapiro HM, Milford EL, Strom TB: Multiparameter flow cytometric analysis of lymphocyte subpopulation activation in lectin-stimulated cultures. J Immunol 128: 2676–2681, 1982.
Krishan A: Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol 66: 188–193, 1974.
Monroe JG, Havran WL, Cambier JC:Blymphocyte activation: entry into cell cycle is accompanied by decreased expression of IgD but not IgM. Eur J Immunol 13: 208–213, 1983.
Monroe JG, Cambier JC: Sorting of B lymphoblasts based upon cell diameter provides cell populations enriched in different stages of cell cycle. J Immunol Methods 63: 45–56, 1983.
Hunter WM: Radioimmunoassay. In: Weir DM (ed). Handbook of Experimental Immunology, third ed, Vol 1. Blackwell Scientific Publications, Oxford, 1978, pp 14.1–14.40.
Carroll AM, Zalutsky M, Schatten S, Perry LL, Bhan A, Sobotka C, Benacerraf B, Greene MI: Monoclonal antibodies to tissue-specific cell surface antigens. I. Characterization of an antibody to a prostate tissue antigen. Cancer Res (submitted).
Marchalonis JJ: An enzymatic method for the trace iodination of immunoglobulin and other proteins. Biochem J 112: 299–305, 1969.
Termer AJ, Lesavre PH, Cooper NR: Purification and radiolabeling of human Clq. J Immunol 127: 648–653, 1981.
Kanellopoulos J, Rossi G, Metzger H: Preparative isolation of the cell receptor for immunoglobulin E. J Biol Chem 254: 7691–7697, 1979.
Mory Y, Chernajovsky Y, Feinstein SI, Chen L, Nir U, Weissenbach J, Malpiece Y, Tiollais P, Marks D, Ladner M, Colby C, Revel M: Synthesis of human interferon Blin Escherichia coli infected by a lambda phage recombinant containing a human genomic fragment. Eur J Biochem 120: 197–202, 1981.
Anderson D, Shapiro L, Shalka AM: In situ immunoassays for translation products. In: Wu R (ed). Methods in Enzymology, Vol 68. Academic Press, New York, 1979, pp 428–436.
Henning U, Royer H-D, Teather RM, Hindennach I, Hollenberg CP: Cloning of the structural gene (omp A) for an integral outer membrane protein of Escherichia coli K-12. Proc Natl Acad Sci USA 76: 4360–4364, 1979.
Young RA, Davis RW: Efficient isolation of genes using antibody probes. Proc Natl Acad Sci USA 80: 1194–1198, 1983.
Kemp DJ, Coppel RL, Cowman AF, Saint RB, Brown GV, Anders RF: Expression of Plasmodium falciparum blood-stage antigens in Escherichia coli: detection with antibodies from immune humans. Proc Natl Acad Sci USA 80: 3787–3791, 1983.
Kaplan DA, Greenfield L, Collier RJ: Chromogenic method to screen very large populations of bacteriophage plaques for the presence of specific antigen. In: Wu, R, Moldave K (eds). Methods in Enzymology, Vol 100. Academic Press, New York, 1983, pp 342–368.
Casadaban MJ, Martinez-Arias A, Shapira SK, Chou J: B-galactosidase gene fusions for analyzing gene expression in Escherichia coli and yeast. In: Wu R, Grossman L, Moldave L (eds). Methods in Enzymology, Vol 100. Academic Press, New York, 1983, pp 293–328.
Villa-Kamaroff L, Efstratiadis A, Broome S, Lomedico P, Tizard R, Naber SP, Chick WL, Gilbert W: A bacterial clone synthesizing proinsulin. Proc Natl Acad Sci USA 75: 3727–3731, 1978.
Clarke L, Hitzeman R, Carbon J: Selection of specific, clones from colony banks by screening with radioactive antibody. In: Wu R (ed). Methods in Enzymology, Vol 68. Academic Press, New York, 1979, pp 436–442.
Erlich HA, Cohen SN, McDevitt HO: Immunological detection and characterization of products translated from cloned DNA fragments. In: Wu R (ed). Methods in Enzymology, Vol 68. Academic Press, New York, 1979, pp 443–453.
Kemp DJ, Cowan AF: Direct immunoassay for detecting Escherichia coli colonies that contain polypeptides encoded by cloned DNA segments. Proc Natl Acad Sci USA 78: 4520–4524, 1981.
Melcher U: The purification of B-glactosidase-specific polysomes by affinity chromatography. Anal Biochem 64: 461–465, 1975.
Eschenfeldt WH, Patterson RJ: Do antibody binding techniques identify polysomes synthesizing a specific protein. Biochem Biophys Res Commun 67: 935–945, 1975.
Groner B, Hynes NE, Sippel AE, Jeep S, Hun MCN, Schutz G: Immunoadsorption of specific chicken oviduct polysomes. J Biol Chem 252: 6666–6674, 1977.
Shapiro SZ, Young JR: An immunochemical method for mRNA purification. J Biol Chem 256: 1495–1498, 1981.
Boyer SH, Smith KD, Noyes AN, Young KE: Adjuvants to immunological methods for mRNA purification. J Biol Chem 258: 2068–2071, 1983.
Korman AJ, Knudsen PJ, Kaufman JF, Strominger JL: cDNA clones for the heavy chain of HLA-DR antigens obtained after immunopurification of polysomes by monoclonal antibody. Proc Natl Acad Sci USA 79: 1844–1848, 1982.
Robson KJH, Chandra T, MacGillivray RTA, Woo SLC: Polysomeimmunoprecipitation of henylalaninehydroxy-lase mRNA from rat liver and cloning of its cDNA. Proc Natl Acad Sci USA 79: 4701–4705, 1982.
Gonzales FJ, Kasper CB: Cloning of epoxide hydratase complementary DNA. J Biol Chem 256: 4697–4700, 1981.
Kraus JP, Rosenberg LE: Purification of low-abundance messenger RNAs from rat liver by polysome immunoadsorption. Proc Natl Acad Sci USA 79: 4015–4019, 1982.
Gurdon JB, Wickens MP: The use of Xenopus oocytes for the expression of cloned genes. In: Wu R, Grossman L, Moldave K (eds). Methods in Enzymology, Vol 101. Academic Press, New York, 1983, pp 370–386.
Gaulton GN, Triplett EL: Control of tyrosinase gene expression and its relationship to neural crest induction in Rana pipiens. I. Isolation and characterization of amphi bian tyrosinase mRNA. J Biol Chem 258: 14839–14844, 1983.
Shapiro DJ, Baker HJ: Purification and characterization of Xenopus laevis vitellogenin messenger RNA. J Biol Chem 252: 5244–5250, 1977.
Graham FL, Van der Eb A: A new technique for the assay for infectivity of human adenovirus 5 DNA. J Virol 52: 455–467, 1973.
Shen Y-M, Hirschhorn RR, Mercer WE, Surmacz E, Tsutsui Y, Soprano KJ, Baserga R: Gene transfer: DNA microinjection compared with DNA transfection with a very high efficiency. Mol Cell Biol 2: 1145–1154, 1982.
Szybalski W, Szybalski EH, Ragni G: Genetic studies with human cell lines. In: Syverton Memorial Symposium. Analytic Cell Culture. Natl Cancer Inst Monogr 7: 75–89, 1962.
Perucho M, Hanahan D, Wigler M: Genetic and physical linkage of exogenous sequences in transformed cells. Cell 22: 309–317, 1980.
Kavathas P, Herzenberg L: Stable transformation of mouse L cells for human membrane T-cell differentiation antigens, HLA and B2 microglobulin: selection by fluores cence-activated cell sorting. Proc Natl Acad Sci USA 80: 524–528, 1983.
Barbosa JA, Kamarck ME, Biro PA, Weissman SM, Ruddle FH: Identification of human genomic clones coding the major histocompatibility antigens HLA-A2 and HLA-B7 by DNA-mediated gene transfer. Proc Natl Acad Sci USA 79: 6327–6331, 1982.
Woodward JG, Orn A, Harmon RC, Goodenow RS, Hood L, Frelinger JA: Specific recognition of the product of a transferred major histocompatibility complex gene by cytotoxic T lymphocytes. Proc Natl Acad Sci USA 79: 3613–3617, 1982.
Goldfarb M, Shimizu K, Perucho M, Wigler M: Isolation and preliminary characterization of a human transforming gene from T24 bladder carcinoma cells. Nature (London) 296: 404–409, 1982.
Di Maio D, Treisman R, Maniatis T: Bovine papillomavirus vector that propagates as a plasmid in both mouse and bacterial cells. Proc Natl Acad Sci USA 79: 4030–4034, 1982.
Schaffner W: Direct transfer of cloned genes from bacteria to mammalian cells. Proc Natl Acad Sci USA 77: 2163–2167, 1980.
Mulligan RC, Berg P: Expression of a bacterial gene in mammalian cells. Science 209: 1422–1427, 1980.
Southern PJ, Berg P: Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet 1: 327–341, 1982.
Agarwal KL, Brumstedt J, Noyes BE: A general method for detection and characterization of an mRNA using an oligonucelotide probe. J Biol Chem 156: 1023–1028, 1981.
Suggs SV, Wallaace RB, Hirose T, Kawashima EH, Itakura K: Use of synthetic oligonucleotides as hybridization probes: isolation of cloned cDNA sequences for human B2-microglobulin. Proc Natl Acad Sci USA 78: 6613–6617, 1981.
Author information
Authors and Affiliations
Additional information
Dr. Gaulton received the NRSA Viral Oncology Training Grant t# CA 09031.
Rights and permissions
About this article
Cite this article
Gaulton, G.N., Co, M.S., Royer, HD. et al. Anti-idiotypic antibodies as probes of cell surface receptors. Mol Cell Biochem 65, 5–21 (1984). https://doi.org/10.1007/BF00226015
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00226015